Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
---|---|---|---|---|---|
KL1-M52H9 | Mouse | Mouse Plasma Kallikrein / KLKB1 Protein, His Tag | ![]() |
![]() ![]() |
|
KL1-H52H9 | Human | Human Plasma Kallikrein / KLKB1 Protein, His Tag (active enzyme, MALS verified) | ![]() |
![]() ![]() |
The purity of Human Plasma Kallikrein/KLKB1, His Tag (Cat. No. KL1-H52H9) is more than 90% and the molecular weight of this protein is around 75-90 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Lanadelumab | 2372V1TKXK (UNII code); X124-G01; SHP-643; DX-2930; TAK-743 | Approved | Dyax Pharma | Takhzyro, 达泽优 | United States | Angioedemas, Hereditary | Dyax Corp | 2018-08-23 | Drug-Related Side Effects and Adverse Reactions; Hypotension; Coronavirus Disease 2019 (COVID-19); Hereditary Autoinflammatory Diseases; Angioedema; Angioedemas, Hereditary; Lung Injury | Details |
Berotralstat | BCX-7353 | Approved | Biocryst Pharmaceuticals Inc | ORLADEYO | United States | Angioedemas, Hereditary | Biocryst Pharmaceuticals Inc | 2020-12-03 | Angioedemas, Hereditary | Details |
Ecallantide | DX-88; EPI-KAL2; FOV-2302; CB-500929 | Approved | Dyax Pharma | Kalbitor | United States | Angioedema | Dyax Corp | 2009-12-01 | Macular Edema; Hereditary Angioedema Types I and II; Blood Loss, Surgical; Angioedemas, Hereditary; Retinal Vein Occlusion; Angioedema | Details |
Lanadelumab | 2372V1TKXK (UNII code); X124-G01; SHP-643; DX-2930; TAK-743 | Approved | Dyax Pharma | Takhzyro, 达泽优 | United States | Angioedemas, Hereditary | Dyax Corp | 2018-08-23 | Drug-Related Side Effects and Adverse Reactions; Hypotension; Coronavirus Disease 2019 (COVID-19); Hereditary Autoinflammatory Diseases; Angioedema; Angioedemas, Hereditary; Lung Injury | Details |
Berotralstat | BCX-7353 | Approved | Biocryst Pharmaceuticals Inc | ORLADEYO | United States | Angioedemas, Hereditary | Biocryst Pharmaceuticals Inc | 2020-12-03 | Angioedemas, Hereditary | Details |
Ecallantide | DX-88; EPI-KAL2; FOV-2302; CB-500929 | Approved | Dyax Pharma | Kalbitor | United States | Angioedema | Dyax Corp | 2009-12-01 | Macular Edema; Hereditary Angioedema Types I and II; Blood Loss, Surgical; Angioedemas, Hereditary; Retinal Vein Occlusion; Angioedema | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Sebetralstat | KVD-900 | Phase 3 Clinical | Kalvista Pharmaceuticals | Angioedemas, Hereditary | Details |
THR-149 | TG-758; THR-149 | Phase 2 Clinical | Bicycle Therapeutics, Thrombogenics Inc | Diabetic macular oedema; Diabetic Retinopathy; Diabetes Mellitus | Details |
QLS-215 | QLS-215; STAR-0215 | Phase 2 Clinical | Quellis Biosciences Inc | Angioedemas, Hereditary | Details |
NTLA-2002 | NTLA-2002 | Phase 2 Clinical | Intellia Therapeutics Inc | Angioedemas, Hereditary | Details |
KVD-001 | KVD-001 | Phase 2 Clinical | Vantia Ltd | Diabetic macular oedema | Details |
MDPK-67b | DM-107; MDPK-67b; MDPK-67 | Phase 1 Clinical | Med Discovery | Prostatic Neoplasms | Details |
Feniralstat | KVD-824 | Phase 1 Clinical | Vantia Ltd | Hereditary Angioedema Types I and II; Angioedemas, Hereditary | Details |
MSB-03 | MSB-03 | Phase 1 Clinical | Rosacea | Details | |
ATN-249 | ATN-249 | Phase 1 Clinical | Attune Pharmaceuticals | Angioedemas, Hereditary | Details |
Sebetralstat | KVD-900 | Phase 3 Clinical | Kalvista Pharmaceuticals | Angioedemas, Hereditary | Details |
THR-149 | TG-758; THR-149 | Phase 2 Clinical | Bicycle Therapeutics, Thrombogenics Inc | Diabetic macular oedema; Diabetic Retinopathy; Diabetes Mellitus | Details |
QLS-215 | QLS-215; STAR-0215 | Phase 2 Clinical | Quellis Biosciences Inc | Angioedemas, Hereditary | Details |
NTLA-2002 | NTLA-2002 | Phase 2 Clinical | Intellia Therapeutics Inc | Angioedemas, Hereditary | Details |
KVD-001 | KVD-001 | Phase 2 Clinical | Vantia Ltd | Diabetic macular oedema | Details |
MDPK-67b | DM-107; MDPK-67b; MDPK-67 | Phase 1 Clinical | Med Discovery | Prostatic Neoplasms | Details |
Feniralstat | KVD-824 | Phase 1 Clinical | Vantia Ltd | Hereditary Angioedema Types I and II; Angioedemas, Hereditary | Details |
MSB-03 | MSB-03 | Phase 1 Clinical | Rosacea | Details | |
ATN-249 | ATN-249 | Phase 1 Clinical | Attune Pharmaceuticals | Angioedemas, Hereditary | Details |
This web search service is supported by Google Inc.